Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With Presbyopia
Clinical trial NCT05665387 · COMPLETED
Trial details
- NCT number
- NCT05665387
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-22
- Primary completion
- 2023-07-27
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.